Systolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Diastolic blood pressure · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Blood pressure target achievement · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
Educational or behavioural interventions for patients showed no clear difference in blood pressure target achievement compared with usual care (moderate certainty).
1 finding from 1 review
Medication adherence (continuous) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
LDL‐cholesterol · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
HbA1c (%) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Body‐mass index (BMI) · The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60…
1 finding from 1 review
Machine usage Hours per night · adults with obstructive sleep apnoea
1 finding from 1 review
1.2 CPAP device usage (hours/night), sensitivity analysis: adherence in control group < four hours/night · adults with obstructive sleep apnoea
1 finding from 1 review
N deemed adherent (≥4 hours/night) · adults with obstructive sleep apnoea
Behavioural intervention leads to higher 3.3 N deemed adherent (≥ four hours/night) compared with control (high certainty).
1 finding from 1 review
1.4 Withdrawal ‐ NO META‐ANALYSIS PERFORMED · adults with obstructive sleep apnoea
Behavioural intervention leads to lower 3.4 Withdrawal compared with control (high certainty).
1 finding from 1 review
Daytime sleepiness (ESS): endpoint score. · adults with obstructive sleep apnoea
1 finding from 1 review
AHI · adults with obstructive sleep apnoea
1 finding from 1 review
QoL · adults with obstructive sleep apnoea
2 findings from 1 review